Literature DB >> 20626552

New features of troponin testing in different clinical settings.

T Omland1.   

Abstract

Cardiac troponin levels are routinely measured for diagnosing acute myocardial infarction. Cardiac troponin measurements also provide information concerning prognosis and the effect of early intervention in patients with acute coronary syndromes. The recent development of highly sensitive cardiac troponin assays permits detection of very low circulating levels. Use of sensitive troponin assays improves overall diagnostic accuracy in patients with suspected acute coronary syndromes, and these assays provide strong prognostic information in stable coronary artery disease and chronic heart failure. However, increased sensitivity comes with a cost of decreased specificity, and serial testing, as well as clinical context and judgment, is likely to become increasingly important in the interpretation of troponin assay results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626552     DOI: 10.1111/j.1365-2796.2010.02253.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  9 in total

1.  Troponin-keep up or be left behind.

Authors:  Aw Tar Choon
Journal:  Malays J Med Sci       Date:  2010-10

2.  A multicentre analysis of troponin use in clinical practice.

Authors:  J D Groarke; L Browne; R Margey; H A McCann; G J Blake; D D Sugrue; N G Mahon
Journal:  Ir J Med Sci       Date:  2012-09-29       Impact factor: 1.568

3.  Troponin in diabetic patients with and without chronic coronary artery disease.

Authors:  Carlos Alexandre Wainrober Segre; Whady Hueb; Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Desiderio Favarato; Celia Maria Cassaro Strunz; Marília da Costa Oliveira Sprandel; Alessandra Roggério; Ana Luiza de Oliveira Carvalho; Raul Cavalcante Maranhão; José Antonio Franchini Ramires; Roberto Kalil Filho
Journal:  BMC Cardiovasc Disord       Date:  2015-07-21       Impact factor: 2.298

4.  The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients.

Authors:  Anke Neukamm; Gunnar Einvik; Arne Didrik Høiseth; Vidar Søyseth; Nils Henrik Holmedahl; Natalia Kononova; Torbjørn Omland
Journal:  BMC Pulm Med       Date:  2016-11-25       Impact factor: 3.317

5.  Biomarkers of cardiovascular injury and stress are associated with increased frequency of ventricular ectopy: a population-based study.

Authors:  Julia Brox Skranes; Gunnar Einvik; Silje Kjeka Namtvedt; Anna Randby; Harald Hrubos-Strøm; Jon Brynildsen; Tor-Arne Hagve; Virend K Somers; Helge Røsjø; Torbjørn Omland
Journal:  BMC Cardiovasc Disord       Date:  2016-11-22       Impact factor: 2.298

6.  Salivary troponin I as an indicator of myocardial infarction.

Authors:  Iraj Mirzaii-Dizgah; Esmail Riahi
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

7.  Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study.

Authors:  Helge Røsjø; Jukka Vaahersalo; Tor-Arne Hagve; Ville Pettilä; Jouni Kurola; Torbjørn Omland
Journal:  Crit Care       Date:  2014-11-08       Impact factor: 9.097

8.  Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.

Authors:  Geeta Gulati; Siri L Heck; Helge Røsjø; Anne H Ree; Pavel Hoffmann; Tor-Arne Hagve; Jon Norseth; Berit Gravdehaug; Kjetil Steine; Jürgen Geisler; Torbjørn Omland
Journal:  J Am Heart Assoc       Date:  2017-11-08       Impact factor: 5.501

9.  Genome-wide association study of cardiac troponin I in the general population.

Authors:  Marta R Moksnes; Helge Røsjø; Anne Richmond; Magnus N Lyngbakken; Sarah E Graham; Ailin Falkmo Hansen; Brooke N Wolford; Sarah A Gagliano Taliun; Jonathon LeFaive; Humaira Rasheed; Laurent F Thomas; Wei Zhou; Nay Aung; Ida Surakka; Nicholas J Douville; Archie Campbell; David J Porteous; Steffen E Petersen; Patricia B Munroe; Paul Welsh; Naveed Sattar; George Davey Smith; Lars G Fritsche; Jonas B Nielsen; Bjørn Olav Åsvold; Kristian Hveem; Caroline Hayward; Cristen J Willer; Ben M Brumpton; Torbjørn Omland
Journal:  Hum Mol Genet       Date:  2021-10-13       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.